Insider Trading: Confidentiality Hasn’t Found Rightful Balance (IOL.co.za)
PRETORIA – Confidentiality is an honourable trait, but institutions are certainly not fanatical about it when their interests are at stake. Looking back, just before and after 1994, we recall some remarkable insider-trading events that shaped our markets. A close relative of insider trading is front running and central to both is confidentiality. Confidentiality is an important and shared human value in Western bioethics and is included in international bioethical guidelines, including the Helsinki declaration. The latter is widely regarded as the cornerstone document on human research ethics. As important as confidentiality is in human health matters, so ought it to be in human financial affairs.
Nobody Is That Lucky, Prosecutor Tells Insider-Trading Jury (Bloomberg)
For anyone to successfully trade five times in a row on health-care mergers, they need inside information, a prosecutor told a jury in the retrial of former Perella Weinberg Partners LP managing director Sean Stewart. “Winning the lottery once takes astronomical odds, winning it five times — that doesn’t happen,” Assistant U.S. Attorney Samson Enzer said in his closing argument Tuesday.
A Director at Fox Factory Holding (NASDAQ: FOXF) is Selling Shares (Analyst Ratings)
Yesterday, a Director at Fox Factory Holding (FOXF), Larry Enterline, sold shares of FOXF for $2.03M. In addition to Larry Enterline, 5 other FOXF executives reported Sell trades in the last month. Based on Fox Factory Holding’s latest earnings report for the quarter ending June 30, the company posted quarterly revenue of $192 million and quarterly net profit of $22.92 million.
Silicon Laboratories Inc (SLAB) CEO George Tyson Tuttle Sold $4.2 million of Shares (Guru Focus)
CEO of Silicon Laboratories Inc., George Tyson Tuttle, sold 36,813 shares of SLAB on 09/16/2019 at an average price of $112.86 a share. The total sale was $4.2 million. Silicon Laboratories Inc is a provider of silicon, software and system solutions for the Internet of Things, Internet infrastructure, industrial control, consumer and automotive markets generating, a majority of its revenue from the Internet of Things.
The CFO & EVP of Ultragenyx Pharmaceutical, Inc. is Exercising Options (Analyst Ratings)
Yesterday it was reported that the CFO & EVP of Ultragenyx Pharmaceutical, Inc. (RARE), Shalini Sharp, exercised options to buy 31,843 RARE shares at $5.53 a share, for a total transaction value of $176.3K. Following this transaction Shalini Sharp’s holding in the company was increased by 75.16% to a total of $4.38 million. In addition to Shalini Sharp, one other RARE executive reported Buy trades in the last month.
